Login / Signup

Takotsubo Multicenter Registry (REMUTA) - Clinical Aspects, In-Hospital Outcomes, and Long-Term Mortality.

Gustavo Luiz Gouvêa de Almeida JuniorJoão Mansur FilhoDenilson Campos de AlbuquerqueSergio Salles XavierÁlvaro PontesElias Pimentel GouvêaAlexandre Bahia Barreiras MartinsNágela S V NunesLilian Vieira CarestiatoJoão Luiz Fernandes PetrizArmando Márcio Gonçalves SantosBruno Santana BandeiraBárbara Elaine de Jesus AbufaiadLuciana da Camara PachecoMaurício Sales de OliveiraPaulo Eduardo Campana Ribeiro FilhoPedro Paulo Nogueres SampaioGustavo Salgado DuqueLuiz Felipe CamillisAndré Casarsa MarquesFrancisco Carlos LourençoJosé Ricardo PalazzoCláudio Ramos da CostaBibiana Almeida da SilvaCleverson Neves ZukowskiRomulo Ribeiro GarciaFernanda de Carvalho ZonisSuzana Andressa Morais de PaulaCarolina Gravano Ferraz FerrariBruno Soares da Silva RangelRoberto Muniz FerreiraBárbara Ferreira da Silva MendesIsabela Ribeiro Carvalho de CastroLeonardo Giglio Gonçalves de SouzaLuiz Henrique Dos Santos AraújoAlexandre Giani
Published in: Arquivos brasileiros de cardiologia (2020)
The results of the REMUTA show that TTS is not a benign pathology, as was once thought, especially regarding the secondary TTS group, which has a high rate of complications and mortality. (Arq Bras Cardiol. 2020; 115(2):207-216).
Keyphrases
  • risk factors
  • cardiovascular events
  • healthcare
  • emergency department
  • type diabetes
  • cross sectional
  • coronary artery disease
  • metabolic syndrome
  • adverse drug
  • adipose tissue
  • skeletal muscle
  • drug induced